Thus, how important the molecular and cell-of-origin definition of HER2 tumours may be to understand BC oncogenesis, the prime interest of the medical community lies in the therapeutic opportunity provided by the identification of homogeneous subgroups and a better understanding of the genetic mechanisms involved. The gene discussed is ERBB2; the disease is breast cancer.